Uncategorized
Myra Vision Announces Positive Initial Outcomes from its Feasibility Study at the 2025 American Glaucoma Society Meeting
Company’s first-of-its-kind titratable glaucoma therapy system aims to optimize intraocular pressure (IOP) reduction for patients with moderate to…